Assessment of Ki67 in breast cancer: updated recommendations from the international Ki67 in breast cancer working group

TO Nielsen, SCY Leung, DL Rimm… - JNCI: Journal of the …, 2021 - academic.oup.com
Abstract Ki67 immunohistochemistry (IHC), commonly used as a proliferation marker in
breast cancer, has limited value for treatment decisions due to questionable analytical …

An overview of triple-negative breast cancer

P Kumar, R Aggarwal - Archives of gynecology and obstetrics, 2016 - Springer
Purpose Triple-negative breast cancer (TNBC) is a heterogeneous group of tumors
comprising various breast cancers simply defined by the absence of estrogen receptor …

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

F Cardoso, S Kyriakides, S Ohno… - Annals of …, 2019 - annalsofoncology.org
In 2018, the predicted number of new breast cancers in 28 European Union (EU) countries
was 404 920, with estimated age-adjusted annual incidence of breast cancer of 144.9/100 …

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

E Senkus, S Kyriakides, S Ohno… - Annals of …, 2015 - annalsofoncology.org
In 2012, the estimated age-adjusted annual incidence of breast cancer in 40 European
countries was 94.2/100 000 and the mortality 23.1/100 000 [1]. The incidence increased …

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆

S Loibl, F André, T Bachelot, CH Barrios… - Annals of …, 2024 - annalsofoncology.org
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
- Annals of Oncology Skip to Main Content Advertisement Annals of Oncology European …

Prognostic value of stromal tumor-infiltrating lymphocytes in young, node-negative, triple-negative breast cancer patients who did not receive (neo) adjuvant systemic …

VMT de Jong, Y Wang, ND Ter Hoeve… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE Triple-negative breast cancer (TNBC) is considered aggressive, and therefore,
virtually all young patients with TNBC receive (neo) adjuvant chemotherapy. Increased …

[HTML][HTML] Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early …

A Goldhirsch, WC Wood, AS Coates, RD Gelber… - Annals of oncology, 2011 - Elsevier
Abstract The 12th St Gallen International Breast Cancer Conference (2011) Expert Panel
adopted a new approach to the classification of patients for therapeutic purposes based on …

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

E Senkus, S Kyriakides, F Penault-Llorca… - Annals of …, 2013 - annalsofoncology.org
In 2008, the estimated age-adjusted annual incidence of breast cancer in Europe (40
countries) was 88.4/100 000 and the mortality 24.3/100 000. The incidence increased after …

Wnt signaling in triple-negative breast cancer

SÖG Pohl, N Brook, M Agostino, F Arfuso, AP Kumar… - Oncogenesis, 2017 - nature.com
Wnt signaling regulates a variety of cellular processes, including cell fate, differentiation,
proliferation and stem cell pluripotency. Aberrant Wnt signaling is a hallmark of many …

Taking ideas and discourse seriously: explaining change through discursive institutionalism as the fourth 'new institutionalism'

VA Schmidt - European political science review, 2010 - cambridge.org
All three of the traditionally recognized new institutionalisms–rational choice, historical, and
sociological–have increasingly sought to 'endogenize'change, which has often meant a turn …